Related Experiment Video

Updated: May 28, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
04:24

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program

Published on: April 19, 2019

Cardiac remodeling at the population level--risk factors, screening, and outcomes

Ola Gjesdal1, David A Bluemke, Joao A Lima

  • 1Division of Cardiology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Blalock 524D1, Baltimore, MD 21287-0845, USA.

Nature Reviews. Cardiology
|October 27, 2011
PubMed

Insights

Heart failure is rising. Early detection of cardiac remodeling, a precursor to heart failure, is crucial for timely intervention and preventing disease progression. This review examines risk factors and screening strategies for subclinical heart failure.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Increasing prevalence of heart failure globally necessitates early detection.
  • Cardiac remodeling, characterized by left ventricular changes, precedes clinical heart failure.
  • Identifying preclinical stages of heart failure is key to effective treatment.

Purpose of the Study:

  • To review population-based studies on cardiac remodeling.
  • To explore associations between cardiac remodeling and various risk factors.
  • To highlight strategies for screening subclinical heart failure.

Main Methods:

  • Review of population-based epidemiological studies.
  • Analysis of risk factors including age, sex, ethnicity, and body composition.
  • Examination of screening strategies for early detection of heart failure.

Main Results:

  • Cardiac remodeling is linked to factors like age, sex, ethnicity, body stature, and disease.
  • Subclinical heart failure can be identified through specific screening approaches.
  • Understanding these associations aids in predicting and preventing heart failure.

Conclusions:

  • Early identification of cardiac remodeling is vital for managing rising heart failure rates.
  • Screening for subclinical heart failure is essential in at-risk populations.
  • Further research into risk factors and screening methods can improve patient outcomes.

More Related Videos

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents07:26

Studying Left Ventricular Reverse Remodeling by Aortic Debanding in Rodents

Published on: July 14, 2021

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...